These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 23651519)
1. SUMO-1 conjugation blocks beta-amyloid-induced astrocyte reactivity. Hoppe JB; Rattray M; Tu H; Salbego CG; Cimarosti H Neurosci Lett; 2013 Jun; 546():51-6. PubMed ID: 23651519 [TBL] [Abstract][Full Text] [Related]
2. P38K and JNK pathways are induced by amyloid-β in astrocyte: Implication of MAPK pathways in astrogliosis in Alzheimer's disease. Saha P; Guha S; Biswas SC Mol Cell Neurosci; 2020 Oct; 108():103551. PubMed ID: 32896578 [TBL] [Abstract][Full Text] [Related]
3. Regulation of synaptic plasticity and cognition by SUMO in normal physiology and Alzheimer's disease. Lee L; Dale E; Staniszewski A; Zhang H; Saeed F; Sakurai M; Fa' M; Orozco I; Michelassi F; Akpan N; Lehrer H; Arancio O Sci Rep; 2014 Dec; 4():7190. PubMed ID: 25448527 [TBL] [Abstract][Full Text] [Related]
4. Modulation of inducible nitric oxide synthase expression by sumoylation. Akar CA; Feinstein DL J Neuroinflammation; 2009 Mar; 6():12. PubMed ID: 19323834 [TBL] [Abstract][Full Text] [Related]
5. The pivotal role of SUMO-1-JNK-Tau axis in an in vitro model of oxidative stress counteracted by the protective effect of curcumin. Buccarello L; Dragotto J; Iorio F; Hassanzadeh K; Corbo M; Feligioni M Biochem Pharmacol; 2020 Aug; 178():114066. PubMed ID: 32502496 [TBL] [Abstract][Full Text] [Related]
6. Alteration of global protein SUMOylation in neurons and astrocytes in response to Alzheimer's disease-associated insults. Maruyama T; Wada H; Abe Y; Niikura T Biochem Biophys Res Commun; 2018 Jun; 500(2):470-475. PubMed ID: 29660340 [TBL] [Abstract][Full Text] [Related]
7. Modulation of Abeta generation by small ubiquitin-like modifiers does not require conjugation to target proteins. Dorval V; Mazzella MJ; Mathews PM; Hay RT; Fraser PE Biochem J; 2007 Jun; 404(2):309-16. PubMed ID: 17346237 [TBL] [Abstract][Full Text] [Related]
8. SUMO and Alzheimer's disease. Lee L; Sakurai M; Matsuzaki S; Arancio O; Fraser P Neuromolecular Med; 2013 Dec; 15(4):720-36. PubMed ID: 23979993 [TBL] [Abstract][Full Text] [Related]
9. E2-mediated small ubiquitin-like modifier (SUMO) modification of thymine DNA glycosylase is efficient but not selective for the enzyme-product complex. Coey CT; Fitzgerald ME; Maiti A; Reiter KH; Guzzo CM; Matunis MJ; Drohat AC J Biol Chem; 2014 May; 289(22):15810-9. PubMed ID: 24753249 [TBL] [Abstract][Full Text] [Related]
10. Profiles of SUMO and ubiquitin conjugation in an Alzheimer's disease model. McMillan LE; Brown JT; Henley JM; Cimarosti H Neurosci Lett; 2011 Sep; 502(3):201-8. PubMed ID: 21843595 [TBL] [Abstract][Full Text] [Related]
11. Small ubiquitin-like modifier (SUMO) conjugation impedes transcriptional silencing by the polycomb group repressor Sex Comb on Midleg. Smith M; Mallin DR; Simon JA; Courey AJ J Biol Chem; 2011 Apr; 286(13):11391-400. PubMed ID: 21278366 [TBL] [Abstract][Full Text] [Related]
12. Endocytosis and Transcytosis of Amyloid-β Peptides by Astrocytes: A Possible Mechanism for Amyloid-β Clearance in Alzheimer's Disease. Domínguez-Prieto M; Velasco A; Tabernero A; Medina JM J Alzheimers Dis; 2018; 65(4):1109-1124. PubMed ID: 30103329 [TBL] [Abstract][Full Text] [Related]
13. Small ubiquitin-like modifier 1-3 conjugation [corrected] is activated in human astrocytic brain tumors and is required for glioblastoma cell survival. Yang W; Wang L; Roehn G; Pearlstein RD; Ali-Osman F; Pan H; Goldbrunner R; Krantz M; Harms C; Paschen W Cancer Sci; 2013 Jan; 104(1):70-7. PubMed ID: 23078246 [TBL] [Abstract][Full Text] [Related]
14. Positive and negative regulation of APP amyloidogenesis by sumoylation. Li Y; Wang H; Wang S; Quon D; Liu YW; Cordell B Proc Natl Acad Sci U S A; 2003 Jan; 100(1):259-64. PubMed ID: 12506199 [TBL] [Abstract][Full Text] [Related]